Efficacy Over Time: Studies indicate that mRNA COVID-19 vaccines, such as those developed by  Pfizer-BioNTech and Moderna, maintain high efficacy shortly after the initial doses but experience a decline in effectiveness over time.

Booster Recommendations: Health authorities recommend booster doses to counteract waning immunity. The U.S. Centers for Disease Control and Prevention (CDC) advises annual COVID-19 vaccinations for individuals aged 12 and older, especially those at higher risk.

Variant Considerations: The emergence of new variants, such as Omicron, has influenced vaccine effectiveness. Updated vaccines targeting specific variants have been developed to enhance protection against severe illness, hospitalization, and death.

Ongoing Research:  Continuous studies are essential to understand the long-term durability of  mRNA vaccine-induced immunity and to inform future vaccination strategies.